Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions
Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations
  • California Research Institute Los Angeles, California, United States
  • BRCR Global Tamarac, Florida, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

NCT05270213

Conditions
Advanced Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • UCLA Hematology/Oncology - Santa Monica Santa Monica, California, United States
View all 14 locations
View Trial Details
Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

NCT05856981

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC, Colorectal Cancer, +47 more
Locations
  • Henry Ford Cancer Institute Detroit, Michigan, United States
  • Washington University Medical Campus St Louis, Missouri, United States
  • Gabrail Cancer & Research Center Canton, Ohio, United States
  • Virginia Cancer Specialists Fairfax, Virginia, United States
View Trial Details
Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

NCT06108050

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
Locations
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • California Cancer Associates for Research and Excellence Fresno, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
View Trial Details
Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT03556228

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +65 more
Locations
  • Providence Medical Foundation (site 209) Santa Rosa, California, United States
  • Hartford Hospital (site 210) Hartford, Connecticut, United States
  • The George Washington University Cancer Center (site 212) Washington D.C., District of Columbia, United States
  • Holy Cross Hospital (site 213) Fort Lauderdale, Florida, United States
View all 15 locations
View Trial Details

Related conditions